MCD
52
2
A
43
2
M
37
12
GOOGL
40
-5
PAYX
53
2
KEY
46
3
STZ
54
-3
AON
54
2
TDC
80
4
XRX
44
3
FE
50
-2
AMG
54
2
ROK
62
15
HRB
57
5
MSFT
50
3
AXP
71
2
ZION
65
2
URI
65
5
GOOG
50
-3
UA
50
-9
MCD
52
2
A
43
2
M
37
12
GOOGL
40
-5
PAYX
53
2
KEY
46
3
STZ
54
-3
AON
54
2
TDC
80
4
XRX
44
3
FE
50
-2
AMG
54
2
ROK
62
15
HRB
57
5
MSFT
50
3
AXP
71
2
ZION
65
2
URI
65
5
GOOG
50
-3
UA
50
-9
Financhill
Back

10x Genomics 10K Form

Sell
40

TXG
10x Genomics

Last Price:
14.30
Seasonality Move:
18.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TXG News And Ratings

See the #1 stock for the next 7 days that we like better than TXG

TXG Financial Statistics

Sales & Book Value

Annual Sales: $618.73M
Cash Flow: $17.75M
Price / Cash Flow: 68.4
Annual Sales: $5.97
Price / Book: 2.4

Profitability

EPS (TTM): -1.53000
Net Income (TTM): $-182.55M
Gross Margin: $409.31M
Return on Equity: -24.99%
Return on Assets: -19.4%

10x Genomics Earnings Forecast

Key 10x Genomics Financial Ratios

  • The Gross Profit Margin over the past 7 years for TXG is 66.15%.
  • The Selling, General & Administrative Expenses for TXG have been equal to 55.49% of Gross Profit Margin.
  • The Research & Development expenses have been 43.69% of Revenue.
  • The Interest Expense is -0.01% of Operating Income.
  • The Net Earning history of TXG is -41.23% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

10x Genomics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: TXG
CUSIP: 88025U
Website: 10xgenomics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.9
Quick Ratio: 3.97

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TXG Technical Analysis vs Fundamental Analysis

Sell
40
10x Genomics (TXG) is a Sell

Is 10x Genomics a Buy or a Sell?

  • 10x Genomics stock is rated a Sell
    The current 10x Genomics [TXG] share price is $14.31. The Score for TXG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.